Although not adequately powered for Overall Survival (OS) analysis, a positive trend was observed. 6 Given the success of immune checkpoint inhibitors (ICIs) in metastatic BUC, their efficacy has also been assessed in the adjuvant setting.
← all excerpts
Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologists.
1
—
—